Publications by authors named "Karin Goodman"

Claim this Profile
T
Tumorgrafts as in vivo surrogates for women with ovarian cancer.
S John Weroha, Marc A Becker, Sergio Enderica-Gonzalez, Sean C Harrington, Ann L Oberg, Karin M Goodman

Clin Cancer Res· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a broad coverage HLA-DR degenerate epitope pool derived from carcinoembryonic antigen.
Lavakumar Karyampudi, Christopher J Krco, Kimberly R Kalli, Courtney L Erskine, Lynn C Hartmann, Karin Goodman

Cancer Immunol Immunother· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional folate receptor alpha is elevated in the blood of ovarian cancer patients.
Eati Basal, Guiti Z Eghbali-Fatourechi, Kimberly R Kalli, Lynn C Hartmann, Karin M Goodman

PLoS One· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An HLA-DR-degenerate epitope pool detects insulin-like growth factor binding protein 2-specific immunity in patients with cancer.
Kimberly R Kalli, Christopher J Krco, Lynn C Hartmann, Karin Goodman, Matthew J Maurer

Cancer Res· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T-cell immunity to the folate receptor alpha is prevalent in women with breast or ovarian cancer.
Keith L Knutson, Christopher J Krco, Courtney L Erskine, Karin Goodman, Linda E Kelemen

J Clin Oncol· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis